An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial
Prognosis in advanced pancreatic ductal adenocarcinoma (aPDAC) is particularly poor, only few patients benefit from treatment, and there are few biomarkers. The PREDICT trial examined whether first-line time-to-treatment failure (TTF1) predicts second-line treatment failure (TTF2) in aPDAC patients...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 July 2025
|
| In: |
Molecular cancer
Year: 2025, Jahrgang: 24, Heft: 1, Pages: 1-19 |
| ISSN: | 1476-4598 |
| DOI: | 10.1186/s12943-025-02406-7 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12943-025-02406-7 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1186/s12943-025-02406-7?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate |
| Verfasserangaben: | Anton Lahusen, Manfred P. Lutz, Rui Fang, Martina Kirchner, Sarah Albus, Klaus Kluck, Meinolf Karthaus, Andreas Schwarzer, Gabriele Siegler, Alexander Kleger, Thomas J. Ettrich, Alexander Becher, Sabine Höfling, Jens T. Siveke, Jan Budczies, Andrea Tannapfel, Albrecht Stenzinger, Phyllis Fung-Yi Cheung, Tim Eiseler and Thomas Seufferlein |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1946038776 | ||
| 003 | DE-627 | ||
| 005 | 20251215101340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251215s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12943-025-02406-7 |2 doi | |
| 035 | |a (DE-627)1946038776 | ||
| 035 | |a (DE-599)KXP1946038776 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lahusen, Anton |e VerfasserIn |0 (DE-588)1384365974 |0 (DE-627)194603942X |4 aut | |
| 245 | 1 | 3 | |a An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer |b lessons from the PREDICT trial |c Anton Lahusen, Manfred P. Lutz, Rui Fang, Martina Kirchner, Sarah Albus, Klaus Kluck, Meinolf Karthaus, Andreas Schwarzer, Gabriele Siegler, Alexander Kleger, Thomas J. Ettrich, Alexander Becher, Sabine Höfling, Jens T. Siveke, Jan Budczies, Andrea Tannapfel, Albrecht Stenzinger, Phyllis Fung-Yi Cheung, Tim Eiseler and Thomas Seufferlein |
| 264 | 1 | |c 22 July 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.12.2025 | ||
| 520 | |a Prognosis in advanced pancreatic ductal adenocarcinoma (aPDAC) is particularly poor, only few patients benefit from treatment, and there are few biomarkers. The PREDICT trial examined whether first-line time-to-treatment failure (TTF1) predicts second-line treatment failure (TTF2) in aPDAC patients but found no association. We hypothesized that the tumor immune microenvironment (TiME) could correlate with the outcome in this trial and assessed whether tissue features were reflected in peripheral blood. | ||
| 650 | 4 | |a Advanced pancreatic ductal adenocarcinoma | |
| 650 | 4 | |a Immunophenotyping | |
| 650 | 4 | |a Liquid biomarkers | |
| 650 | 4 | |a Machine learning | |
| 650 | 4 | |a Peripheral blood mononuclear cells | |
| 650 | 4 | |a Second-line chemotherapy | |
| 650 | 4 | |a Tumor immune microenvironment | |
| 700 | 1 | |a Lutz, Manfred P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fang, Rui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirchner, Martina |d 1973- |e VerfasserIn |0 (DE-588)1017178976 |0 (DE-627)676266363 |0 (DE-576)353239747 |4 aut | |
| 700 | 1 | |a Albus, Sarah |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kluck, Klaus |e VerfasserIn |0 (DE-588)122679940X |0 (DE-627)1747876127 |4 aut | |
| 700 | 1 | |a Karthaus, Meinolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwarzer, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siegler, Gabriele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kleger, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ettrich, Thomas J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Becher, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Höfling, Sabine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siveke, Jens T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 700 | 1 | |a Tannapfel, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Cheung, Phyllis Fung-Yi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eiseler, Tim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seufferlein, Thomas |d 1963- |e VerfasserIn |0 (DE-588)1100314660 |0 (DE-627)859268187 |0 (DE-576)469593067 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer |d London : Biomed Central, 2002 |g 24(2025), 1, Artikel-ID 202, Seite 1-19 |h Online-Ressource |w (DE-627)355987619 |w (DE-600)2091373-4 |w (DE-576)107015234 |x 1476-4598 |7 nnas |a An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer lessons from the PREDICT trial |
| 773 | 1 | 8 | |g volume:24 |g year:2025 |g number:1 |g elocationid:202 |g pages:1-19 |g extent:19 |a An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer lessons from the PREDICT trial |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12943-025-02406-7 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1186/s12943-025-02406-7?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20251215 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 17 | ||
| 998 | |g 124086403 |a Budczies, Jan |m 124086403:Budczies, Jan |d 910000 |d 912000 |e 910000PB124086403 |e 912000PB124086403 |k 0/910000/ |k 1/910000/912000/ |p 15 | ||
| 998 | |g 122679940X |a Kluck, Klaus |m 122679940X:Kluck, Klaus |d 910000 |d 912000 |d 50000 |e 910000PK122679940X |e 912000PK122679940X |e 50000PK122679940X |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 6 | ||
| 998 | |g 1017178976 |a Kirchner, Martina |m 1017178976:Kirchner, Martina |d 910000 |d 912000 |e 910000PK1017178976 |e 912000PK1017178976 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 999 | |a KXP-PPN1946038776 |e 482802185X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"22 July 2025"}],"title":[{"title_sort":"immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer","subtitle":"lessons from the PREDICT trial","title":"An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer"}],"person":[{"display":"Lahusen, Anton","given":"Anton","family":"Lahusen","role":"aut"},{"display":"Lutz, Manfred P.","given":"Manfred P.","family":"Lutz","role":"aut"},{"given":"Rui","family":"Fang","display":"Fang, Rui","role":"aut"},{"display":"Kirchner, Martina","family":"Kirchner","given":"Martina","role":"aut"},{"role":"aut","display":"Albus, Sarah","family":"Albus","given":"Sarah"},{"role":"aut","display":"Kluck, Klaus","family":"Kluck","given":"Klaus"},{"role":"aut","display":"Karthaus, Meinolf","given":"Meinolf","family":"Karthaus"},{"display":"Schwarzer, Andreas","family":"Schwarzer","given":"Andreas","role":"aut"},{"display":"Siegler, Gabriele","family":"Siegler","given":"Gabriele","role":"aut"},{"role":"aut","family":"Kleger","given":"Alexander","display":"Kleger, Alexander"},{"family":"Ettrich","given":"Thomas J.","display":"Ettrich, Thomas J.","role":"aut"},{"display":"Becher, Alexander","given":"Alexander","family":"Becher","role":"aut"},{"display":"Höfling, Sabine","given":"Sabine","family":"Höfling","role":"aut"},{"role":"aut","display":"Siveke, Jens T.","given":"Jens T.","family":"Siveke"},{"role":"aut","family":"Budczies","given":"Jan","display":"Budczies, Jan"},{"role":"aut","display":"Tannapfel, Andrea","given":"Andrea","family":"Tannapfel"},{"role":"aut","family":"Stenzinger","given":"Albrecht","display":"Stenzinger, Albrecht"},{"given":"Phyllis Fung-Yi","family":"Cheung","display":"Cheung, Phyllis Fung-Yi","role":"aut"},{"family":"Eiseler","given":"Tim","display":"Eiseler, Tim","role":"aut"},{"role":"aut","display":"Seufferlein, Thomas","family":"Seufferlein","given":"Thomas"}],"note":["Gesehen am 15.12.2025"],"relHost":[{"part":{"year":"2025","issue":"1","text":"24(2025), 1, Artikel-ID 202, Seite 1-19","volume":"24","pages":"1-19","extent":"19"},"disp":"An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer lessons from the PREDICT trialMolecular cancer","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"recId":"355987619","id":{"eki":["355987619"],"zdb":["2091373-4"],"issn":["1476-4598"]},"note":["Gesehen am 25.06.20"],"pubHistory":["1.2002 -"],"title":[{"title_sort":"Molecular cancer","title":"Molecular cancer"}],"origin":[{"dateIssuedDisp":"2002-","publisherPlace":"London","publisher":"Biomed Central","dateIssuedKey":"2002"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["Anton Lahusen, Manfred P. Lutz, Rui Fang, Martina Kirchner, Sarah Albus, Klaus Kluck, Meinolf Karthaus, Andreas Schwarzer, Gabriele Siegler, Alexander Kleger, Thomas J. Ettrich, Alexander Becher, Sabine Höfling, Jens T. Siveke, Jan Budczies, Andrea Tannapfel, Albrecht Stenzinger, Phyllis Fung-Yi Cheung, Tim Eiseler and Thomas Seufferlein"]},"id":{"eki":["1946038776"],"doi":["10.1186/s12943-025-02406-7"]},"recId":"1946038776","language":["eng"],"physDesc":[{"extent":"19 S.","noteIll":"Diagramme"}]} | ||
| SRT | |a LAHUSENANTIMMUNERESP2220 | ||